NEVVI Medicare utilization intelligence
or

← back

Provider profile

SRIRATANA, PRAMERN M.D.

Hematology-Oncology · NPI 1174522189 · NORMAL, IL

1
Groups
71
Codes · 2024
195,755
Disclosed services

SRIRATANA, PRAMERN is a Hematology-Oncology in NORMAL, IL, a member of 1 medical group, who billed 71 distinct codes to Medicare Part B in 2024.

Groups: MID-ILLINOIS HEMATOLOGY ONCOLOGY ASSOCIATES LTD (NORMAL, IL)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

195,755
disclosed services
71
codes billed to Medicare Part B
Prior year · CY2023 272,188 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J0897 Injection, denosumab, 1 mg
J1756 Injection, iron sucrose, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
J1626 Injection, granisetron hydrochloride, 100 mcg
80053 Blood test, comprehensive group of blood chemicals
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96375 Injection of additional new drug or substance into vein
83615 Lactate dehydrogenase (enzyme) level
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
82784 Gammaglobulin (immune system protein) measurement
96372 Injection of drug or substance under skin or into muscle
Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg
96413 Administration of chemotherapy into vein, 1 hour or less
J9045 Injection, carboplatin, 50 mg
J3490 Unclassified drugs
83521 Measurement of immunoglobulin light chains
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
83540 Iron level
83550 Iron binding capacity
85055 Reticulated (young) platelet measurement
82728 Ferritin (blood protein) level
96415 Administration of chemotherapy into vein, each additional hour
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
84443 Blood test, thyroid stimulating hormone (tsh)
J7050 Infusion, normal saline solution, 250 cc
96361 Infusion into a vein for hydration, each additional hour
J1200 Injection, diphenhydramine hcl, up to 50 mg
84439 Thyroxine (thyroid chemical), free
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
J2250 Injection, midazolam hydrochloride, per 1 mg
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
82248 Bilirubin level, direct
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
96417 Administration of additional new drug or substance into vein, 1 hour or less
84153 Psa (prostate specific antigen) measurement, total
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
85007 Microscopic examination for white blood cells with manual cell count
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
J7030 Infusion, normal saline solution , 1000 cc
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
96360 Infusion into a vein for hydration, 31-60 minutes
85046 Red blood count automated, with additional calculations
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
83735 Magnesium level
82378 Carcinoembryonic antigen (cea) protein level
96374 Injection of drug or substance into vein
99153 Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes
99308 Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, 20 minutes or more
38222 Biopsy and aspiration of bone marrow sample for diagnosis
99152 Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
J3010 Injection, fentanyl citrate, 0.1 mg
82607 Cyanocobalamin (vitamin b-12) level
86304 Immunologic analysis for detection of tumor antigen, quantitative; ca 125
82306 Vitamin d-3 level
80048 Blood test, basic group of blood chemicals (calcium, total)
82746 Folic acid level, serum
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
G0103 Prostate cancer screening; prostate specific antigen test (psa)
85651 Red blood cell sedimentation rate, to detect inflammation, non-automated

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.